How to ATP-binding cassette transporter?

Q: How to ATP-binding cassette transporter?

Modulators of ATP-binding cassette transporters,Modulators of ATP-binding cassette transporters,Modulators of ATP-Binding Cassette transporters,Modulators of ATP-Binding Cassette transporters,Modulators of ATP-binding cassette transporters

ATP-binding cassette transporter patented technology retrieval search results - Eureka

Modulators of ATP-binding cassette transporters

ActiveUS7495103B2Cosmetic preparationsOrganic active ingredientsDiseaseATP-binding cassette transporter

The present invention relates to modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator, compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators.

Modulators of ATP-binding cassette transporters

View all

Owner:VERTEX PHARMA INC

Modulators of ATP-binding cassette transporters

ActiveUS7776905B2BiocideCompound screeningDiseaseMedicine

Compounds of the present invention and pharmaceutically acceptable compositions thereof, are useful as modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (“CFTR”). The present invention also relates to methods of treating ABC transporter mediated diseases using compounds of the present invention.

View all

Owner:VERTEX PHARMA INC

Modulators of ATP-Binding Cassette transporters

ActiveUS20050059687A1Reduce severityBiocideOrganic active ingredientsATP-binding cassette transporterCystic fibrosis transmembrane conductance regulator

The present invention relates to modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (“CFTR”), compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators.

View all

Owner:VERTEX PHARMA INC

Modulators of ATP-Binding Cassette transporters

ActiveUS7671221B2BiocideNervous disorderDiseaseMedicine

Compounds of the present invention and pharmaceutically acceptable compositions thereof, are useful as modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (“CFTR”). The present invention also relates to methods of treating ABC transporter mediated diseases using compounds of the present invention.

View all

Owner:VERTEX PHARMA INC

Modulators of ATP-binding cassette transporters

ActiveUS7691902B2BiocideSenses disorderDiseaseATP-binding cassette transporter

Compounds of the present invention and pharmaceutically acceptable compositions thereof, are useful as modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (“CFTR”). The present invention also relates to methods of treating ABC transporter mediated diseases using compounds of the present invention.

View all

Owner:VERTEX PHARMA INC

Thiazoles and oxazoles useful as modulators of ATP-Binding Cassette transporters

ActiveUS7407976B2BiocideSenses disorderDiseaseThiazole

The present invention relates to modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Regulator (“CFTR”), compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators.

Thiazoles and oxazoles useful as modulators of ATP-Binding Cassette transporters

View all

Owner:VERTEX PHARMA INC

Modulators of ATP-Binding Cassette Transporters

InactiveUS20100144798A1BiocideSenses disorderDiseaseATP-binding cassette transporter

The present invention relates to modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Regulator (“CFTR”), compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators.

View all

Owner:VERTEX PHARMA INC

Modulators of ATP-binding cassette transporters

ActiveUS7977322B2BiocideSenses disorderATP-binding cassette transporterCystic fibrosis transmembrane conductance regulator

The present invention relates to modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (“CFTR”), compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators.

View all

Owner:VERTEX PHARMA INC

Modulators of ATP-binding cassette transporters

ActiveUS20060052358A1BiocideSenses disorderATP-binding cassette transporterCystic fibrosis transmembrane conductance regulator

The present invention relates to modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (“CFTR”), compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators.

View all

Owner:VERTEX PHARMA INC

Modulators of atp-binding cassette-transporters

ActiveUS20090143381A1BiocideSenses disorderDiseaseATP-binding cassette transporter

Compounds of the present invention, and pharmaceutically acceptable compositions thereof, are useful as modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (“CFTR”). The present invention also relates to methods of treating ABC transporter mediated diseases using compounds of the present invention.

View all

Owner:VERTEX PHARMA INC

Modulators of ATP-binding cassette transporters

ActiveUS20060074075A1Organic active ingredientsCosmetic preparationsDiseaseATP-binding cassette transporter

The present invention relates to modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator, compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators.

View all

Owner:VERTEX PHARMA INC

Modulators of ATP-binding cassette transporters

ActiveUS8354427B2BiocideSenses disorderDiseaseATP-binding cassette transporter

The present invention relates to modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator, compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators.

View all

Owner:VERTEX PHARMA INC

Modulators of ATP-binding cassette transporters

ActiveUS20070105833A1BiocideSenses disorderATP-binding cassette transporterCystic fibrosis transmembrane conductance regulator

4-amido-pyrimidine compounds, derivatives and compositions thereof, and synthetic methods described herein are useful for modulating ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (“CFTR”). The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators.

View all

Owner:VERTEX PHARMA INC

Modulators of ATP-binding cassette transporters

ActiveUS8642609B2Organic active ingredientsBiocideDiseaseATP-binding cassette transporter

The present invention relates to modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (“CFTR”), compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators.

View all

Owner:VERTEX PHARMA INC

Modulators of ATP-binding cassette transporters

ActiveUS8242149B2BiocideSenses disorderDiseaseATP-binding cassette transporter

The present invention relates to modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (“CFTR”), compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators.

View all

Owner:VERTEX PHARMA INC

Modulators of atp-binding cassette transporters

InactiveUS20120184583A1BiocideSenses disorderDiseaseATP-binding cassette transporter

The present invention relates to modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Regulator (“CFTR”), compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators.

View all

Owner:VERTEX PHARMA INC

Modulators of ATP-binding cassette transporters

ActiveUS8314256B2BiocideSenses disorderDiseaseATP-binding cassette transporter

The present invention relates to modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (“CFTR”), compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators.

View all

Owner:VERTEX PHARMA INC

Modulators of ATP-binding cassette transporters

ActiveUS20070244159A1BiocideCompound screeningDiseaseATP-binding cassette transporter

Compounds of the present invention and pharmaceutically acceptable compositions thereof, are useful as modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (“CFTR”). The present invention also relates to methods of treating ABC transporter mediated diseases using compounds of the present invention.

View all

Owner:VERTEX PHARMA INC

Modulators of ATP-binding cassette transporters

ActiveUS20080019915A1Reduce severityBiocideSenses disorderDiseaseATP-binding cassette transporter

Compounds of the present invention, and pharmaceutically acceptable compositions thereof, are useful as modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (“CFTR”). The present invention also relates to methods of treating ABC transporter mediated diseases using compounds of the present invention.

View all

Owner:VERTEX PHARMA INC

Modulators of ATP-Binding Cassette transporters

ActiveUS8802700B2BiocideSenses disorderDiseaseATP-binding cassette transporter

The present invention relates to modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator, compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators.

View all

Owner:VERTEX PHARMA INC

Modulators of atp-binding cassette transporters

ActiveUS20130116238A1BiocideSenses disorderDiseaseATP-binding cassette transporter

Compounds of the present invention and pharmaceutically acceptable compositions thereof, are useful as modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (“CFTR”). The present invention also relates to methods of treating ABC transporter mediated diseases using compounds of the present invention.

View all

Owner:VERTEX PHARMA INC

Modulators of ATP-binding cassette-transporters

ActiveUS8507524B2BiocideSenses disorderDiseaseATP-binding cassette transporter

Compounds of the present invention, and pharmaceutically acceptable compositions thereof, are useful as modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (“CFTR”). The present invention also relates to methods of treating ABC transporter mediated diseases using compounds of the present invention.

View all

Owner:VERTEX PHARMA INC

Modulators of ATP-Binding Cassette transporters

ActiveUS20050176789A1BiocideOrganic active ingredientsDiseaseATP-binding cassette transporter

The present invention relates to modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including CF Transmembrane Regulator (“CFTR”), compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators.

View all

Owner:VERTEX PHARMA INC

Modulators of atp-binding cassette transporters

InactiveUS20140343098A1Reduce severityBiocideTissue cultureDiseaseATP-binding cassette transporter

The present invention relates to modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator, compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators.

View all

Owner:VERTEX PHARMA INC

Modulators of ATP-binding cassette transporters

ActiveUS20070264196A1Reduce severityBiocideSenses disorderDiseaseATP-binding cassette transporter

The present invention relates to modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (“CFTR”), compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators.

View all

Owner:VERTEX PHARMA INC

Modulators of ATP-binding cassette transporters

ActiveUS8822451B2BiocideSenses disorderDiseaseMedicine

4-amido-pyrimidine compounds, derivatives and compositions thereof, and synthetic methods described herein are useful for modulating ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (“CFTR”). The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators.